FDA Commissioner Scott Gottlieb outlined these 4 general strategic approaches to address the problems of increasing antimicrobial resistance and a lack of new antibiotics being developed.
FDA: Here Is The 2019 Strategic Approach To Combat Antimicrobial Resistance
